Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment of human milk.
Babylat has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in January 2026.
Babylat's investors include MassChallenge Switzerland, Business Angels Switzerland (BAS), Swiss-Polish government, Ypsomed Innovation Fund.
Babylat is headquartered in Bern, Switzerland.
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment of human milk.
Babylat is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Babylat — Funding & Investors." VCBacked, January 19, 2026, https://www.vcbacked.co/company/babylat. Accessed July 20, 2026.
VCBacked. (2026). Babylat — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/babylat
{{cite web |title=Babylat — Funding & Investors |url=https://www.vcbacked.co/company/babylat |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated